Publicaciones en colaboración con investigadores/as de University of Lyon System (12)

2024

  1. Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer–a plain language summary

    Future Oncology, Vol. 20, Núm. 22, pp. 1531-1544

2023

  1. Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer

    European Journal of Cancer, Vol. 189

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Laparoscopic posterior segmental resections: How I do it: Tips and pitfalls

    International Journal of Surgery

  2. Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma

    PLoS ONE, Vol. 15, Núm. 9 September

  3. OBEDIS Core Variables Project: European Expert Guidelines on a Minimal Core Set of Variables to Include in Randomized, Controlled Clinical Trials of Obesity Interventions

    Obesity Facts, Vol. 13, Núm. 1, pp. 1-28

  4. Repurposing infectious disease vaccines for intratumoral immunotherapy

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

2018

  1. Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility

    Nature Communications, Vol. 9, Núm. 1

  2. Gut roundtable meeting paper: Selected recent advances in hepatocellular carcinoma

    Gut, Vol. 67, Núm. 2, pp. 380-388

2016

  1. Routine Clinical Practice for Patients with Recurrent Ovarian Carcinoma: Results from the TROCADERO Study

    International Journal of Gynecological Cancer, Vol. 26, Núm. 2, pp. 240-247

2014

  1. An ANOCEF genomic and transcriptomic microarray study of the response to irinotecan and bevacizumab in recurrent glioblastomas

    BioMed Research International, Vol. 2014

2011

  1. Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer

    Liver International, Vol. 31, Núm. 10, pp. 1542-1553